日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effects of CT-388, a once-weekly signaling-biased dual GLP-1/GIP receptor agonist, on weight loss and glycemic control in preclinical models and participants with obesity

CT-388 是一种每周一次给药的信号传导偏向型双重 GLP-1/GIP 受体激动剂,本研究探讨了其对临床前模型和肥胖患者体重减轻和血糖控制的影响。

Chakravarthy, Manu V; Rodriguez, Ruben; Hergarden, Anne; Elliott, Michael A; Frias, Juan P; Argüelles-Tello, Federico A; Tenorio, Edgar; Rankin, Jonathan E; Wu, Jingtao; Krishnan, Shyam; Erlanson, Daniel A; Fucini, Raymond V; Bone, Derek; Iwig, Jeffrey S; Acosta, Luis; Untereiner, Ashley; Pant, Asmita; Patton, Avalon; Sanchez-Sanchez, Leyla L; Luo, Jian; Steinberg, Alexandra; Bialonczyk, Damian; Hansen, Stig K

A practical method for determining the rate of covalent modification of fragments and leads

一种测定片段和先导化合物共价修饰速率的实用方法

Jeon, Janice; Kholodar, Svetlana A; Tran, Brian H; Mallinger, Kimberly E; Erlanson, Daniel A; Everley, Robert A

Where and how to house big data on small fragments

如何以及在哪里将大数据存储在小块数据中

Erlanson, Daniel A; Burley, Stephen K; Fearon, Daren; Fraser, James S; Kreitler, Dale; Nonato, Maria Cristina; Sakai, Naoki; Wollenhaupt, Jan; Weiss, Manfred S

Biased agonism of GLP-1R and GIPR enhances glucose lowering and weight loss, with dual GLP-1R/GIPR biased agonism yielding greater efficacy.

GLP-1R 和 GIPR 的偏向性激动作用可增强降血糖和减肥效果,而 GLP-1R/GIPR 的双重偏向性激动作用可产生更大的疗效

Rodriguez Ruben, Hergarden Anne, Krishnan Shyam, Morales Marikris, Lam Davina, Tracy Ted, Tang Teresa, Patton Avalon, Lee Craig, Pant Asmita, Erlanson Daniel A, Enquist Johan, Bone Derek, Fucini Ray, Bialonczyk Damian, Hansen Stig K, Luo Jian, Chakravarthy Manu V

Clinical Relatedness and Stability of vigiVec Semantic Vector Representations of Adverse Events and Drugs in Pharmacovigilance

vigiVec语义向量表示在药物警戒中对不良事件和药物的临床相关性和稳定性

Erlanson, Nils; China, Joana Félix; Taavola, Henric; Norén, G Niklas

Astrocyte to neuron reprogramming with NeuroD1 for repair in canine stroke.

利用 NeuroD1 将星形胶质细胞重编程为神经元以修复犬中风。

Clark Isaac H, Roushdy Zachary, Natera-Rodriguez Dilmareth, Sun Kevin, Erlanson Olivia, Khedr Shaimaa, Low Walter C, Grande Andrew W

Elderly long-term survivors in the Nordic phase II study with first-line maintenance temozolomide for primary central nervous system lymphoma: a 10-year follow-up

北欧 II 期研究中接受一线维持治疗替莫唑胺治疗原发性中枢神经系统淋巴瘤的老年长期生存者:10 年随访

Pulczynski, Elisa Jacobsen; Simonsen, Mikkel Runason; Kuittinen, Outi; Fagerli, Unn-Merete; Erlanson, Martin; Fluge, Øystein; Leppä, Sirpa; Østenstad, Bjørn; Fosså, Alexander; Eriksson, Mikael; El-Galaly, Tarec; Kuitunen, Hanne; Papworth, Karin; Ljungqvist, Maria; Pedersen, Martin B; Pollari, Marjukka

Semimethylation is a feature of diffuse large B-cell lymphoma, and subgroups with poor prognosis are characterized by global hypomethylation and short telomere length

半甲基化是弥漫性大 B 细胞淋巴瘤的特征,预后不良的亚组以整体低甲基化和端粒长度较短为特征

Olivia Carlund, Elina Thörn, Pia Osterman, Maja Fors, Andy Dernstedt, Mattias N E Forsell, Martin Erlanson, Mattias Landfors, Sofie Degerman, Magnus Hultdin

Comparative dose effectiveness of intravenous and intrathecal AAV9.CB7.hIDS, RGX-121, in mucopolysaccharidosis type II mice

静脉注射和鞘内注射 AAV9.CB7.hIDS、RGX-121 对 II 型粘多糖贮积症小鼠的剂量效果比较

Miles C Smith, Lalitha R Belur, Andrea D Karlen, Olivia Erlanson, Justin Furcich, Troy C Lund, Davis Seelig, Kelley F Kitto, Carolyn A Fairbanks, Kwi Hye Kim, Nick Buss, R Scott McIvor

Generation and characterization of an immunodeficient mouse model of mucopolysaccharidosis type II

粘多糖贮积症 II 型免疫缺陷小鼠模型的建立及鉴定

Miles C Smith, Lalitha R Belur, Andrea D Karlen, Kelly Podetz-Pedersen, Olivia Erlanson, Kanut Laoharawee, Justin Furcich, Troy C Lund, Yun You, Davis Seelig, Beau R Webber, R Scott McIvor